Plain-English translation of NCT05242861 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a retrospective study, which means researchers will look back at medical records from women who have already received brachytherapy treatment for various gynecological cancers—including cervical, uterine, ovarian, vulvar, and vaginal cancer. By reviewing these past cases, the research team hopes to learn more about how effective this treatment has been and what outcomes patients have experienced. This is not a study where you receive new treatment; instead, the team uses existing information to improve their understanding.
Gynecological cancers affect many women, and brachytherapy is an established treatment option, but doctors want to gather more detailed information about how well it works in different situations. By studying real patient experiences and outcomes, researchers can better understand which patients benefit most and how to improve care in the future.
You likely qualify if…
You likely don't qualify if…
If you qualify, the research team will ask to review your medical records—including information about your diagnosis, the brachytherapy treatment you received, and your outcomes afterward. You will not receive any new treatment or attend multiple visits; this is purely a records review study. Your participation helps researchers understand treatment patterns and results so they can better help future patients.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
China
Enrollment target
~300 participants
Started
February 2022
Primary completion
December 2024
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 80 Years
Sex
Female only
Last updated on clinicaltrials.gov in February 2022.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.